Literature DB >> 29503441

Characterization and allergic role of IL-33-induced neutrophil polarization.

Bo Sun1, Linnan Zhu1, Yaling Tao1, Hai-Xi Sun1, Yang Li1, Peng Wang1, Yuzhu Hou1, Yang Zhao1, Xiaodong Zhang2, Lianfeng Zhang3, Ning Na4, Yong Zhao5.   

Abstract

Neutrophils are involved in the pathogenesis of allergy. However, the contribution of the different functionally polarized neutrophils in allergy needs to be clarified. We sought to define the characteristics of interleukin (IL)-33-induced neutrophils and the involvement of this subset of polarized neutrophils in allergic pathogenesis. Freshly isolated neutrophils were treated with different cytokines and the cytokine expression levels were detected by real-time PCR. The gene expression profile of IL-33-induced neutrophils was determined by microarray assay. Adoptive transfer assay was used to investigate the function of IL-33-induced neutrophils in an ovalbumin (OVA)-induced allergic asthma model. IL-33-treated neutrophils selectively produced IL-4, IL-5, IL-9 and IL-13 (referred as to N(IL-33) cells) and displayed a distinctive gene expression profile in sharp contrast to resting and lipopolysaccharide (LPS)-treated neutrophils. IL-33-induced neutrophils expressed high Levels of IL-1R2 on cell surface, whereas resting and LPS-treated neutrophils did not, indicating IL-1R2 might be used as a biomarker for N(IL-33) cells. Importantly, N(IL-33) neutrophils exist in the lungs of OVA-induced allergic asthma mice. Adoptive transfer of N(IL-33) neutrophils significantly promotes the severity of the lung pathogenesis in this model. IL-33 induces neutrophil polarization through c-Jun N-terminal kinase- and nuclear factor-κB-dependent pathways. A previously unappreciated neutrophil polarization driven by IL-33 with unique cell surface markers and cytokine/chemokine-producing gene profile was defined. The newly identified N(IL-33) subpopulation may have significant contribution to IL-33-related pathogenesis.

Entities:  

Keywords:  IL-33; IL-9; allergy; asthma; inflammation; neutrophils; polarization

Mesh:

Substances:

Year:  2018        PMID: 29503441      PMCID: PMC6141612          DOI: 10.1038/cmi.2017.163

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  53 in total

Review 1.  Targeting IL-33 in autoimmunity and inflammation.

Authors:  Theoharis C Theoharides; Anastasia I Petra; Alexandra Taracanova; Smaro Panagiotidou; Pio Conti
Journal:  J Pharmacol Exp Ther       Date:  2015-04-23       Impact factor: 4.030

Review 2.  Targeting neutrophilic inflammation in severe neutrophilic asthma: can we target the disease-relevant neutrophil phenotype?

Authors:  Piet L B Bruijnzeel; Mohib Uddin; Leo Koenderman
Journal:  J Leukoc Biol       Date:  2015-05-14       Impact factor: 4.962

3.  Smad3-deficient CD11b(+)Gr1(+) myeloid-derived suppressor cells prevent allograft rejection via the nitric oxide pathway.

Authors:  Tingting Wu; Chenming Sun; Zhigang Chen; Yu Zhen; Jianxia Peng; Zhongquan Qi; Xiao Yang; Yong Zhao
Journal:  J Immunol       Date:  2012-10-08       Impact factor: 5.422

Review 4.  Neutrophil recruitment and function in health and inflammation.

Authors:  Elzbieta Kolaczkowska; Paul Kubes
Journal:  Nat Rev Immunol       Date:  2013-03       Impact factor: 53.106

5.  The inhibitory effect of IFN-γ on protease HTRA1 expression in rheumatoid arthritis.

Authors:  Yuzhu Hou; Haijiang Lin; Linnan Zhu; Zhaoting Liu; Fanlei Hu; Jianfeng Shi; Tao Yang; Xiaoyun Shi; Huifang Guo; Xiaotian Tan; Lianfeng Zhang; Qiang Wang; Zhanguo Li; Yong Zhao
Journal:  J Immunol       Date:  2014-06-06       Impact factor: 5.422

6.  Association of IL33-IL-1 receptor-like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood.

Authors:  Olga E Savenije; Jestinah M Mahachie John; Raquel Granell; Marjan Kerkhof; F Nicole Dijk; Johan C de Jongste; Henriëtte A Smit; Bert Brunekreef; Dirkje S Postma; Kristel Van Steen; John Henderson; Gerard H Koppelman
Journal:  J Allergy Clin Immunol       Date:  2014-02-22       Impact factor: 10.793

7.  Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice.

Authors:  A Gessner; H Blum; M Röllinghoff
Journal:  Immunobiology       Date:  1993-12       Impact factor: 3.144

8.  The signaling suppressor CIS controls proallergic T cell development and allergic airway inflammation.

Authors:  Xuexian O Yang; Huiyuan Zhang; Byung-Seok Kim; Xiaoyin Niu; Juan Peng; Yuhong Chen; Romica Kerketta; Young-Hee Lee; Seon Hee Chang; David B Corry; Demin Wang; Stephanie S Watowich; Chen Dong
Journal:  Nat Immunol       Date:  2013-06-02       Impact factor: 25.606

9.  Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis.

Authors:  Baptiste N Jaeger; Jean Donadieu; Céline Cognet; Claire Bernat; Diana Ordoñez-Rueda; Vincent Barlogis; Nizar Mahlaoui; Aurore Fenis; Emilie Narni-Mancinelli; Blandine Beaupain; Christine Bellanné-Chantelot; Marc Bajénoff; Bernard Malissen; Marie Malissen; Eric Vivier; Sophie Ugolini
Journal:  J Exp Med       Date:  2012-03-05       Impact factor: 14.307

10.  Effect of everolimus on the immunomodulation of the human neutrophil inflammatory response and activation.

Authors:  Damien Vitiello; Paul-Eduard Neagoe; Martin G Sirois; Michel White
Journal:  Cell Mol Immunol       Date:  2014-06-02       Impact factor: 11.530

View more
  21 in total

1.  Spaceflight/microgravity inhibits the proliferation of hematopoietic stem cells by decreasing Kit-Ras/cAMP-CREB pathway networks as evidenced by RNA-Seq assays.

Authors:  Peng Wang; Hongling Tian; Jiayu Zhang; Juanjuan Qian; Ling Li; Lu Shi; Yong Zhao
Journal:  FASEB J       Date:  2019-02-05       Impact factor: 5.191

2.  Kinetics of the accumulation of group 2 innate lymphoid cells in IL-33-induced and IL-25-induced murine models of asthma: a potential role for the chemokine CXCL16.

Authors:  Yan Li; Shihao Chen; Yafei Chi; Yiran Yang; Xiwen Chen; Huating Wang; Zhe Lv; Jingjing Wang; Linjie Yuan; Ping Huang; Kewu Huang; Chris J Corrigan; Wei Wang; Sun Ying
Journal:  Cell Mol Immunol       Date:  2018-11-22       Impact factor: 11.530

Review 3.  The dichotomous function of interleukin-9 in cancer diseases.

Authors:  K Gerlach; B Weigmann
Journal:  J Mol Med (Berl)       Date:  2019-08-08       Impact factor: 4.599

4.  Macrophage-intrinsic DUOX1 contributes to type 2 inflammation and mucus metaplasia during allergic airway disease.

Authors:  Carolyn R Morris; Aida Habibovic; Christopher M Dustin; Caspar Schiffers; Miao-Chong Lin; Jennifer L Ather; Yvonne M W Janssen-Heininger; Matthew E Poynter; Olaf Utermohlen; Martin Krönke; Albert van der Vliet
Journal:  Mucosal Immunol       Date:  2022-06-02       Impact factor: 8.701

5.  Spaceflight and simulated microgravity suppresses macrophage development via altered RAS/ERK/NFκB and metabolic pathways.

Authors:  Lu Shi; Hongling Tian; Peng Wang; Ling Li; Zhaoqi Zhang; Jiayu Zhang; Yong Zhao
Journal:  Cell Mol Immunol       Date:  2020-01-03       Impact factor: 11.530

Review 6.  Rethinking neutrophils and eosinophils in chronic rhinosinusitis.

Authors:  Tim Delemarre; Bruce S Bochner; Hans-Uwe Simon; Claus Bachert
Journal:  J Allergy Clin Immunol       Date:  2021-04-21       Impact factor: 14.290

7.  The functional diversity of neutrophils and clustered polarization of immunity.

Authors:  Yanan Xu; Qian Zhang; Yong Zhao
Journal:  Cell Mol Immunol       Date:  2020-02-24       Impact factor: 22.096

Review 8.  Interleukin-33: Its Emerging Role in Allergic Diseases.

Authors:  Wen Ding; Gui-Lin Zou; Wei Zhang; Xing-Ning Lai; Hou-Wen Chen; Li-Xia Xiong
Journal:  Molecules       Date:  2018-07-09       Impact factor: 4.411

Review 9.  IL33 and Mast Cells-The Key Regulators of Immune Responses in Gastrointestinal Cancers?

Authors:  Moritz F Eissmann; Michael Buchert; Matthias Ernst
Journal:  Front Immunol       Date:  2020-07-03       Impact factor: 7.561

Review 10.  The Janus Face of IL-33 Signaling in Tumor Development and Immune Escape.

Authors:  Mi-Ran Choi; Jeffrey A Sosman; Bin Zhang
Journal:  Cancers (Basel)       Date:  2021-06-30       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.